Trump Claims Unrealistic Drug Price Cuts Draw Skepticism

President Donald Trump has made highly exaggerated claims about drastically cutting pharmaceutical drug prices in the United States, stating reductions of up to 1,500%, figures that critics and social media users have deemed mathematically impossible since a 100% reduction would mean free drugs and anything beyond that implies negative pricing. Trump emphasized he has convinced drug companies to comply, even threatening luxury car brands linked to pharmaceutical firms with bans in the U.S. if prices are not lowered. Despite signing an executive order invoking "most-favored nation" status to align U.S. drug prices with those of other countries, the details of the plan remain unclear, and pharmaceutical executives have described talks as inconclusive. Social media and AI chatbots widely mocked the president's rhetoric as hyperbolic and unrealistic, highlighting the absurdity of the proposed percentage cuts. While drug pricing is a bipartisan concern, Trump's numerical claims have overshadowed the policy discussion, raising skepticism about the feasibility of his approach. This follows a pattern of Trump making bold but unsubstantiated assertions on economic and political issues.